Cano Health Total Non-Operating Income/Expense 2020-2024 | CANOQ
Cano Health total non-operating income/expense from 2020 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
| Cano Health Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2023 | $-96 |
| 2022 | $11 |
| 2021 | $18 |
| 2020 | $-70 |
| 2019 | $-10 |
| Cano Health Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-367 |
| 2023-12-31 | $-23 |
| 2023-09-30 | $-25 |
| 2023-06-30 | $-27 |
| 2023-03-31 | $-21 |
| 2022-12-31 | $63 |
| 2022-09-30 | $-82 |
| 2022-06-30 | $17 |
| 2022-03-31 | $12 |
| 2021-12-31 | $44 |
| 2021-09-30 | $-31 |
| 2021-06-30 | $16 |
| 2021-03-31 | $-11 |
| 2020-12-31 | $-47 |
| 2020-09-30 | $-17 |
| 2020-06-30 | $-6 |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.596B | 25.24 |
| CVS Health (CVS) | United States | $77.976B | 9.69 |
| Elevance Health (ELV) | United States | $62.251B | 8.37 |
| Cencora (COR) | United States | $56.726B | 19.74 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $20.342B | 16.50 |
| Natera (NTRA) | United States | $19.203B | 0.00 |
| BioMerieux (BMXMF) | France | $16.276B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.050B | 0.00 |
| Solventum (SOLV) | United States | $12.516B | 13.25 |
| ICON (ICLR) | Ireland | $11.276B | 10.48 |
| Revvity (RVTY) | United States | $10.693B | 18.40 |
| Viatris (VTRS) | United States | $10.446B | 3.59 |
| Medpace Holdings (MEDP) | United States | $8.878B | 22.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.792B | 0.00 |
| Avantor (AVTR) | United States | $8.409B | 12.22 |
| HealthEquity (HQY) | United States | $8.395B | 36.77 |
| Charles River Laboratories (CRL) | United States | $7.357B | 14.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.197B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.928B | 29.02 |
| BrightSpring Health Services (BTSG) | United States | $3.465B | 31.79 |
| Sotera Health (SHC) | United States | $3.125B | 17.76 |
| Surgery Partners (SGRY) | United States | $2.866B | 37.27 |
| Concentras Parent (CON) | United States | $2.557B | 14.78 |
| Alignment Healthcare (ALHC) | United States | $2.473B | 0.00 |
| Organon (OGN) | United States | $2.457B | 2.61 |
| GeneDx Holdings (WGS) | United States | $2.235B | 86.09 |
| Progyny (PGNY) | United States | $1.966B | 43.28 |
| PACS (PACS) | United States | $1.771B | 0.00 |
| Premier (PINC) | United States | $1.723B | 13.08 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Ardent Health (ARDT) | United States | $1.566B | 6.68 |
| Teladoc Health (TDOC) | United States | $1.461B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.232B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.086B | 8.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.886B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.711B | 6.66 |
| CareDx (CDNA) | United States | $0.710B | 11.09 |
| Nutex Health (NUTX) | United States | $0.618B | 9.35 |
| Embecta (EMBC) | United States | $0.601B | 4.05 |
| So-Young (SY) | China | $0.581B | 0.00 |
| SBC Medicals (SBC) | United States | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| LifeMD (LFMD) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.149B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |